共 50 条
- [1] Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphomaBLOOD ADVANCES, 2022, 6 (18) : 5285 - 5294Villa, DiegoHoster, EvaHermine, OlivierKlapper, WolframSzymczyk, MichalBosly, AndreUnterhalt, MichaelRimsza, Lisa M.Ramsower, Colleen A.Freeman, Ciara L.Scott, David W.Gerrie, Alina S.Savage, Kerry J.Sehn, Laurie H.Dreyling, Martin
- [2] Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphomaBLOOD ADVANCES, 2020, 4 (05) : 858 - 867Merryman, Reid W.Edwin, NatashaRedd, RobertBsat, JadChase, MatthewLaCasce, AnnFreedman, ArnoldJacobson, CaronFisher, DavidNg, SamuelCrombie, JenniferKim, AustinOdejide, OreofeDavids, Matthew S.Brown, Jennifer R.Jacene, HeatherCashen, AmandaBartlett, Nancy L.Mehta-Shah, NehaGhobadi, ArminKahl, BradJoyce, RobinArmand, PhilippeJacobsen, Eric
- [3] Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphomaScientific Reports, 9Sumita RatnasingamJoshua CasanJake ShorttEliza HawkesMichael GilbertsonZoe McQuiltenGeorge GrigoriadisKay Thwe HtunSwe Myo HtetPhilip CampbellKhai Li ChaiHang QuachSushrut PatilStephen Opat
- [4] Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphomaSCIENTIFIC REPORTS, 2019, 9 (1)Ratnasingam, SumitaCasan, JoshuaShortt, JakeHawkes, ElizaGilbertson, MichaelMcQuilten, ZoeGrigoriadis, GeorgeHtun, Kay ThweHtet, Swe MyoCampbell, PhilipChai, Khai LiQuach, HangPatil, SushrutOpat, Stephen
- [5] RITUXIMAB, BENDAMUSTINE AND CYTARABINE AS INDUCTION THERAPY IN ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA: A PHASE 2 STUDY FROM THE FONDAZIONE ITALIANA LINFOMIHAEMATOLOGICA, 2015, 100 : 4 - 4Visco, C.Chiappella, A.Franceschetti, S.Patti, C.Ferrero, S.Barbero, D.Evangelista, A.Spina, M.Molinari, A.Rigacci, L.Tani, M.Di Rocco, A.Pinotti, G.Fabbri, A.Zambello, R.Finotto, S.Gotti, M.Carella, A. M.Salvi, F.Pileri, S. A.Ladetto, M.Zaja, F.Gaidano, G.Vitolo, U.Rodeghiero, F.
- [6] Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell LymphomaBLOOD, 2019, 134Villa, DiegoSehn, Laurie H.Savage, Kerry J.Toze, Cynthia L.Song, Kevinden Brok, Wendie L.Freeman, Ciara L.Scott, David W.Gerrie, Alina S.
- [7] Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphomaBLOOD ADVANCES, 2020, 4 (15) : 3486 - 3494Villa, DiegoSehn, Laurie H.Savage, Kerry J.Toze, Cynthia L.Song, Kevinden Brok, Wendie D.Freeman, Ciara L.Scott, David W.Gerrie, Alina S.
- [8] Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine plus Rituximab without Autologous TransplantBLOOD, 2019, 134Hill, Brian T.Switchenko, Jeffrey M.Martin, PeterChurnetski, Michael C.Sawalha, YazeedGoyal, SubirShanmugasundaram, KrithikaCalzada, OscarKolla, BhaskarBachanova, VeronikaGerson, James N.Barta, Stefan K.Gordon, Max J.Danilov, AlexeyGrover, Natalie S.Mathews, StephanieBurkart, MadelynKarmali, ReemGhosh, NilanjanPark, Steven I.Epperla, NarendranathBond, David A.Badar, TalhaBlum, Kristie A.Guo, JinHamadani, MehdiFenske, Timothy S.Malecek, Mary-KateKahl, Brad S.Flowers, Christopher R.Cohen, Jonathon B.
- [9] Rituximab/bendamustine/cytarabine for transplant-eligible patients with mantle cell lymphoma: A retrospective studyCANCER MEDICINE, 2023, 12 (11): : 12548 - 12552Shimizu, YukiKaji, DaisukeWatanabe, OtoyaYamaguchi, KyosukeKageyama, KoseiTaya, YukiNishida, AyaIshiwata, KazuyaTakagi, ShinsukeYamamoto, HisashiMori, Yuki-AsanoWake, AtsushiUchida, NaoyukiTaniguchi, ShuichiYamamoto, Go